Skip to main content

Perspective Therapeutics, Inc.

For the period ended Jun 30, 2025. Filed Aug 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 13, 2025

CATX$0.84+6.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I · FINANCIAL INFORMATION
Item 1Financial Statements1
Condensed Consolidated Balance Sheets as of June 30, 2025 (unaudited) and December 31, 20241
Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2025 and 2024 (unaudited)2
Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2025 and 2024 (unaudited)3
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended June 30, 2025 and 2024 (unaudited)4
Notes to the Unaudited Condensed Consolidated Financial Statements5
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3Quantitative and Qualitative Disclosures About Market Risk29
Item 4Controls and Procedures29
PART IIOTHER INFORMATION
Item 1Legal Proceedings30
Item 1ARisk Factors30
Item 2Unregistered Sales of Equity Securities and Use of Proceeds30
Item 3Defaults Upon Senior Securities30
Item 4Mine Safety Disclosures30
Item 5Other Information30
Item 6Exhibits31
Signatures32

iii

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.